Global Non-alcoholic Steatohepatitis Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

List of Figures, Tables and Charts Available in Global Non-alcoholic Steatohepatitis Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

List of Tables
Table 1. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-alcoholic Steatohepatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Non-alcoholic Steatohepatitis Product and Services
Table 6. AstraZeneca Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Arena Pharmaceuticals Major Business
Table 10. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 11. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Arena Pharmaceuticals Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Non-alcoholic Steatohepatitis Product and Services
Table 16. GSK Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 19. Novo Nordisk Major Business
Table 20. Novo Nordisk Non-alcoholic Steatohepatitis Product and Services
Table 21. Novo Nordisk Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novo Nordisk Recent Developments/Updates
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Non-alcoholic Steatohepatitis Product and Services
Table 26. Roche Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Roche Recent Developments/Updates
Table 28. Vivus Basic Information, Manufacturing Base and Competitors
Table 29. Vivus Major Business
Table 30. Vivus Non-alcoholic Steatohepatitis Product and Services
Table 31. Vivus Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Vivus Recent Developments/Updates
Table 33. Arisaph Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Arisaph Pharmaceuticals Major Business
Table 35. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 36. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Arisaph Pharmaceuticals Recent Developments/Updates
Table 38. Cempra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Cempra Pharmaceuticals Major Business
Table 40. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 41. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Cempra Pharmaceuticals Recent Developments/Updates
Table 43. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Galectin Therapeutics Major Business
Table 45. Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 46. Galectin Therapeutics Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Galectin Therapeutics Recent Developments/Updates
Table 48. Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Galmed Pharmaceuticals Major Business
Table 50. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 51. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Galmed Pharmaceuticals Recent Developments/Updates
Table 53. Genfit Basic Information, Manufacturing Base and Competitors
Table 54. Genfit Major Business
Table 55. Genfit Non-alcoholic Steatohepatitis Product and Services
Table 56. Genfit Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Genfit Recent Developments/Updates
Table 58. Gilead Basic Information, Manufacturing Base and Competitors
Table 59. Gilead Major Business
Table 60. Gilead Non-alcoholic Steatohepatitis Product and Services
Table 61. Gilead Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Gilead Recent Developments/Updates
Table 63. Immuron Basic Information, Manufacturing Base and Competitors
Table 64. Immuron Major Business
Table 65. Immuron Non-alcoholic Steatohepatitis Product and Services
Table 66. Immuron Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Immuron Recent Developments/Updates
Table 68. Interceptpharma Basic Information, Manufacturing Base and Competitors
Table 69. Interceptpharma Major Business
Table 70. Interceptpharma Non-alcoholic Steatohepatitis Product and Services
Table 71. Interceptpharma Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Interceptpharma Recent Developments/Updates
Table 73. Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Raptor Pharmaceutical Major Business
Table 75. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product and Services
Table 76. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Raptor Pharmaceutical Recent Developments/Updates
Table 78. Takeda Basic Information, Manufacturing Base and Competitors
Table 79. Takeda Major Business
Table 80. Takeda Non-alcoholic Steatohepatitis Product and Services
Table 81. Takeda Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Takeda Recent Developments/Updates
Table 83. Tobira Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Tobira Therapeutics Major Business
Table 85. Tobira Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 86. Tobira Therapeutics Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Tobira Therapeutics Recent Developments/Updates
Table 88. Verva Basic Information, Manufacturing Base and Competitors
Table 89. Verva Major Business
Table 90. Verva Non-alcoholic Steatohepatitis Product and Services
Table 91. Verva Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Verva Recent Developments/Updates
Table 93. Viking Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. Viking Therapeutics Major Business
Table 95. Viking Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 96. Viking Therapeutics Non-alcoholic Steatohepatitis Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Viking Therapeutics Recent Developments/Updates
Table 98. Global Non-alcoholic Steatohepatitis Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 99. Global Non-alcoholic Steatohepatitis Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Non-alcoholic Steatohepatitis Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 101. Market Position of Manufacturers in Non-alcoholic Steatohepatitis, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Non-alcoholic Steatohepatitis Production Site of Key Manufacturer
Table 103. Non-alcoholic Steatohepatitis Market: Company Product Type Footprint
Table 104. Non-alcoholic Steatohepatitis Market: Company Product Application Footprint
Table 105. Non-alcoholic Steatohepatitis New Market Entrants and Barriers to Market Entry
Table 106. Non-alcoholic Steatohepatitis Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Non-alcoholic Steatohepatitis Sales Quantity by Region (2018-2023) & (MT)
Table 108. Global Non-alcoholic Steatohepatitis Sales Quantity by Region (2024-2029) & (MT)
Table 109. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Non-alcoholic Steatohepatitis Average Price by Region (2018-2023) & (USD/Kg)
Table 112. Global Non-alcoholic Steatohepatitis Average Price by Region (2024-2029) & (USD/Kg)
Table 113. Global Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 114. Global Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 115. Global Non-alcoholic Steatohepatitis Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Non-alcoholic Steatohepatitis Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Non-alcoholic Steatohepatitis Average Price by Type (2018-2023) & (USD/Kg)
Table 118. Global Non-alcoholic Steatohepatitis Average Price by Type (2024-2029) & (USD/Kg)
Table 119. Global Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 120. Global Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 121. Global Non-alcoholic Steatohepatitis Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Non-alcoholic Steatohepatitis Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Non-alcoholic Steatohepatitis Average Price by Application (2018-2023) & (USD/Kg)
Table 124. Global Non-alcoholic Steatohepatitis Average Price by Application (2024-2029) & (USD/Kg)
Table 125. North America Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 126. North America Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 127. North America Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 128. North America Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 129. North America Non-alcoholic Steatohepatitis Sales Quantity by Country (2018-2023) & (MT)
Table 130. North America Non-alcoholic Steatohepatitis Sales Quantity by Country (2024-2029) & (MT)
Table 131. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 134. Europe Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 135. Europe Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 136. Europe Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 137. Europe Non-alcoholic Steatohepatitis Sales Quantity by Country (2018-2023) & (MT)
Table 138. Europe Non-alcoholic Steatohepatitis Sales Quantity by Country (2024-2029) & (MT)
Table 139. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 142. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 143. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 144. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 145. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Region (2018-2023) & (MT)
Table 146. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity by Region (2024-2029) & (MT)
Table 147. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 150. South America Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 151. South America Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 152. South America Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 153. South America Non-alcoholic Steatohepatitis Sales Quantity by Country (2018-2023) & (MT)
Table 154. South America Non-alcoholic Steatohepatitis Sales Quantity by Country (2024-2029) & (MT)
Table 155. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Type (2018-2023) & (MT)
Table 158. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Type (2024-2029) & (MT)
Table 159. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Application (2018-2023) & (MT)
Table 160. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Application (2024-2029) & (MT)
Table 161. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Region (2018-2023) & (MT)
Table 162. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity by Region (2024-2029) & (MT)
Table 163. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Non-alcoholic Steatohepatitis Raw Material
Table 166. Key Manufacturers of Non-alcoholic Steatohepatitis Raw Materials
Table 167. Non-alcoholic Steatohepatitis Typical Distributors
Table 168. Non-alcoholic Steatohepatitis Typical Customers
List of Figures
Figure 1. Non-alcoholic Steatohepatitis Picture
Figure 2. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type in 2022
Figure 4. Solid Examples
Figure 5. Liquid Examples
Figure 6. Global Non-alcoholic Steatohepatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Application in 2022
Figure 8. Oral Examples
Figure 9. Parenteral Examples
Figure 10. Global Non-alcoholic Steatohepatitis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Non-alcoholic Steatohepatitis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Non-alcoholic Steatohepatitis Sales Quantity (2018-2029) & (MT)
Figure 13. Global Non-alcoholic Steatohepatitis Average Price (2018-2029) & (USD/Kg)
Figure 14. Global Non-alcoholic Steatohepatitis Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Non-alcoholic Steatohepatitis by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Non-alcoholic Steatohepatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Non-alcoholic Steatohepatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Non-alcoholic Steatohepatitis Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Non-alcoholic Steatohepatitis Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Non-alcoholic Steatohepatitis Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Non-alcoholic Steatohepatitis Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Non-alcoholic Steatohepatitis Average Price by Type (2018-2029) & (USD/Kg)
Figure 29. Global Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Non-alcoholic Steatohepatitis Average Price by Application (2018-2029) & (USD/Kg)
Figure 32. North America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Non-alcoholic Steatohepatitis Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Non-alcoholic Steatohepatitis Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2018-2029)
Figure 52. China Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Non-alcoholic Steatohepatitis Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Non-alcoholic Steatohepatitis Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Non-alcoholic Steatohepatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Non-alcoholic Steatohepatitis Market Drivers
Figure 73. Non-alcoholic Steatohepatitis Market Restraints
Figure 74. Non-alcoholic Steatohepatitis Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis in 2022
Figure 77. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis
Figure 78. Non-alcoholic Steatohepatitis Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source

Keyplayers in Global Non-alcoholic Steatohepatitis Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Takeda
Tobira Therapeutics
Verva
Viking Therapeutics